Have you ever thought of getting a view of your genetic behaviour through an astrological analogy or derive its taxonomy to get a broader perspective of your overall existence? Mapmygenome’s flagship offering “Genomepatri” studies the genetic sequence to trace the ancestral root and heritable diseases to help people revise their lifestyle choices.
CoE IoT Official Blog
Mapmygenome®: Deriving valuable insights from DNA to empower people take charge of their well- being.
Founded in 2012 by two passionate entrepreneurs Anu Acharya and Subash Lingareddy, Mapmygenome® offers advanced health solutions that are formulated by combining genetic health profiles and health history with genetic counseling. The objective of the company is to acquaint people about their health by analysing their genetic history and providing actionable steps that can assist them and the doctor’s move towards a healthier and better life.
Anu Acharya’s entrepreneurial instincts persuaded her to start her entrepreneurial journey with Ocimum Bio solutions. This enterprising initiative was co-founded by IIT Kharagpur alumnus Subash Lingareddy. Their syndicate led to the establishment of a promising molecular diagnostics company- Mapmygenome®- one of the few companies in the country that work towards mitigating the gap between healthcare and personal health through cutting-edge technology and personal genomics. This information can help eliminate, prevent, treat and manage various types of hereditary diseases.
Backed by a powerful team of biotechnologists, statisticians, geneticists, bio informaticians, and medical counselors, Mapmygenome® brainstormed a wide spectrum of products and services, which also bestows healthcare providers with valuable information about their patients. This reduces the time and effort invested in analyzing and treating an ailment.
How do they work?
- Genomepatri Cardio: Genomics-based predictive risk assessment and management panel for cardiovascular diseases and diabetes.
- MyNutriGene: This helps in discovering the connection between genetics and diet. Through MyNutriGene individuals can conduct a detailed analysis of their eating habits which can have a huge impact on their fitness and help prevent diseases.
- MEDICAMAP: A cutting-edge pharmacogenomics test, which analyses an individual’s drug-response profile, based on genetic makeup.
- myfitgene: A program helps achieve cardio-respiratory fitness, muscle strength & endurance, body composition that aids in improving the strength and stamina of the body.
- Genomepatri Heritage: As the name suggests, this provision helps in unearthing the people’s ancestral origins. It decodes the DNA sequence and familiarizes people with their roots and their genetic behaviour.
- Genomepatri Immunity: A tool that enables users to identify gaps in immunity, including essential vitamins and minerals that contribute to immunity. This test also predicts risk for SARS-CoV and cytokine storm (adverse symptom of COVID-19).
Mapmygenome® has also invented other avant-garde offerings such as TB Test Kit, NGS Tests, Genetic Counseling, and Chromosomal Microarray Analysis (CMA). Taking a step further, the company has taken the initiative of conducting comprehensive screening of cancer using genomics. Each solution is composed of latest technology and sequencing platform that observes a simple and non-invasive sampling.
The company brought into play its creativity and innovation to mint Covisafe™- a collection kit for COVID diagnostic testing. CSIR-Centre for cellular and molecular biology validated and certified the kit to be as per ICMR protocols. The kit’s exclusive feature is the nasopharyngeal/oropharyngeal swab that is used to be placed in a stabilizing solution containing RNAShield™ (a proprietary US FDA approved reagent from US-based Zymo Research. The team designed Covisafe™ to ensure the safety of the healthcare providers and staff who collect the specimens. This kit is easy to handle and can be used in the labs. It is compatible with RNA extraction kits, does not require cold-chain transport and can be stored at temperatures less than 25 degrees for about 30 days. The kit does not allow the fluid sample to deteriorate even after passing through multiple freeze-thaw cycles.
When the first case of COVID-19 was diagnosed in India, their team worked round the clock to develop Genomepatri Immunity and an RT-PCR based COVID-19 test. They were among the first private labs in the state to offer NABL and ICMR approved tests to the public. Today, they have 2 labs (including one at Hyderabad International Airport) and many COVID-19 sample collection centers including drive-thru centers. They have expanded their portfolio to include antibody testing, rapid testing, and so forth.
Mapmygenome® has had an incredible journey of pioneering genomic technology and redefining the dimension of wellness and health by exploring individual genetic traits. The firm has created a niche for itself in the personal genomics industry, setting national and global footprints. In 2020, the company collaborated with Apollo Clinic to launch DNA-based health tests.
NASSCOM Center of Excellence IoT& AI vouchsafed Mapmygenome® with the opportunity of showcasing their successes in implementing digital technologies in healthcare, at its flagship healthcare initiative at the seventh edition of Lifesciences & Healthcare Innovation Forum (LHIF). This participation got them great interest from individuals as well as HCPs.
“Some of our recent achievements include the winning of ‘Technologies for Rural Healthcare’ category of 2019 edition, Achiever of the Pride of Telangana – 2018 awards in the Start-up category, Nasscom Emerge 50 2015 – League of 10 Profile, and many. We have bagged US$1.1 million in a pre-series A round of funding from Google India MD RajanAnandan and other angel investors in 2015 and concluded a deal that enabled us to secure around $20 million,” says Anu Acharya, Co-Founder & CEO, Mapmygenome®.
Mapmygenome® has set the bar high: it aims to expand its team, leadership, and counselling network. It endeavours to touch 100 million lives and save a million in the coming decade.
For any further information\query you can write to us at Co-innovate@nasscom.in
YogiFi: Developing innovative systems and intelligent solutions that make holistic wellness accessible for everyone!
The pandemic has pushed us into embracing a new way of living where we remain confined and isolated. This unprecedented change has caused a severe impact on our mental and physical well-being which is why many have turned to the art of Yoga to curtail stress, enhance health, boost immunity, battle chronic diseases and build harmony between the mind, body, and soul.
The Bangalore-based start-up, WELLNESYS is integrating ancient science with modern technology to deliver holistic wellness, assisting people to create and customize the best online and offline yoga. It puts forward a wide range of yoga learning sessions and meditation content that suits all ages, gender, and body. These sessions are curated by global experts who aspire to help people achieve the much-needed mental and physical discipline and peacefulness in times of this coronavirus pandemic.
WELLNESYS was one of the 12 start-ups which made it to the fifth edition of the Qualcomm Design in India Challenge-QDIC 2020, an initiative by Qualcomm that encourages design houses and product companies to invent useful and innovative hardware product designs incorporating Qualcomm chipset platforms and technologies. It ended the QDIC incubation as a second runner up. Qualcomm has been a very actively engaged partner of CoEIoT.
“Qualcomm Design-in-India Challenge has opened the doors for Make-in-India for our start-up. Qualcomm leadership team has been very supportive of our start-up journey, making meaningful connections, at the right time. The patent incentive has been really helpful as we could file more patents in the process,” states MuralidharSomisetty, CEO & Founder, YogiFi.
The fountainhead of Wellnesys, MuralidharSomisetty found solace in yoga for treating his spine injury without undergoing any surgery. The miraculous advantage of this holistic science encouraged him to pursue the art and propagate it. He soon came across the underlying challenges in the adoption and effectiveness of online yoga sessions. To mitigate this problem, he masterminded an award-winning product, YogiFi to revolutionize holistic wellness in the healthcare and fitness technology landscape, making yoga an integral part of our everyday routine.
“YogiFi is here to motivate, guide, and help every individual adopt the culture and exercise the healing power of yoga; guiding them towards a healthy and happy lifestyle. During the pandemic, the YogiFi app delivered at-home interactive yoga sessions using computer vision (camera of a smartphone) besides the smart mat solution with patented asana tracking technology. Each session is curated based on the insightful data and various metrics gathered from the mat: strength, alignment, flexibility, and endurance. Users can now understand the effectiveness of the yoga session with vitals data correlated from wearables such as Apple Watch,” he adds.
The start-up has leveraged technologies like Sensors, IoT, edge computing, AI, Computer Vision, and Apps to create an absolute wellness solution that synthesizes a nonpareil online and offline yoga studio experience at home. Its smart and eco-friendly yoga mats are sensor-equipped and are designed to be paired with the mobile app for enabling an interactive and immersive yoga class experience. These yoga mats can be connected with YogiFi App that acts like personal trainers, extending advanced interactive sessions, tracking the user’s activity & progress, and give real-time feedback on postures and flexibility. YogiFi delivers interactive and immersive yoga classes straight to an individual’s home using the fusion of smart mat and computer vision. YogiFi’s Virtual Studio feature in the app transports users (virtually) to exotic landscapes such as the Himalayas, Forest, Beach, and more by using AR/VR technology. This innovative solution is called “Yoga By Nature” and creates a real-life learning experience amidst a virtual yet aesthetic ambiance. YogiFi is also looking at launching a feature soon to enable user to practice along with a personal trainer or even participate in a fun challenge with any of their friends or peers on the YogiFi’s community leader board. It is compatible with wearables such as Apple Watch, FitBit for biofeedback and well-integrated with smart ecosystem products such as Google Home, Smart TV and others.
Within two years of its establishment, YogiFi has set a strong foot in the international market and has been successful in its endeavour of becoming a smart wellness companion, delivering technology-enabled solutions that are accessible by everyone, anywhere, and at any time. This initiative has won the company an array of innovation awards and global recognition with multiple media mentions.
Under the aegis of the Make-in-India initiative and local assembly line, YogiFi envisages developing a lighter version of the product that is affordable and fits into the price-sensitive markets such as India, Asia-Pacific region. It aims to make yoga classes accessible across socio-geo-demographic boundaries and gamify the learning process through modern technologies.
For any further information\query you can write to us at Co-innovate@nasscom.in
CARER: An Integrative and Holistic platform that ensures Personalized Cancer Care!
The word cancer has been tormenting families for many centuries now. The diagnosis of this disease causes a lot of physical and psychological distress to patients and their families. Founder & CEO of CARER, Samara Mahindra’s subjective encounter with cancer has been an eye-opener where she realized that there were only methodical approaches availed for treating cancer and no emphasis is given to the quality of life or measures that can effectively support pre-cancer and post-cancer treatment. Intending to provide the sick and their family the support they need in their cancer journey, Samara along with a masterly team of Oncologists, Patients, and Science structured the foundation of Personalized Cancer Care providing platform- CARER that aims to be a ray of hope for people battling cancer and helping them heal, feel and live better.
Headquartered in Bangalore, CARER is on its mission of establishing a unique AI-driven integrative oncology health tech solution that will focus on 360-degree interactivity and connection between every health service provider, partner & patient, in-depth health tracking, therapeutic intervention, community building, data and content management. It offers an extensive range of programs that can be categorized into three parts-Integrative therapy for treatment, Integrative therapy for post-treatment, and Nutrition for Cancer.
The efficient team of Carer put their brains together to think up exclusive methodologies and therapies that consist of Nutrition Therapy, Movement & Meditation Therapy, and Mental Well-Being Therapy. One can also find recipe books, Cancer Essentials Guidebook, and other quality products that suit the needs of the patients at the CARER store. Since day one, CARER has been diligently working towards building credibility and evidence through clinical trials and patient pilot studies. They have curated a unique methodology that has proven to enhance cancer patients’ condition in multiple factors and parameters, curtailing their side-effects, improving immunity, and ensuring better treatment outcomes.
Additionally, CARER is advancing services to support patients recovering and healing from COVID as well as cancer. “At CARER, we made sure to provide services that supported efficient delivery of services and immediate response to our patients through technology. We have created certain specific therapeutic interventions for COVID-positive cancer patients and have partnered with other homecare service providers to make sure that our patients are getting access to high quality COVID care at home,” Samara Mahindra, Founder & CEO of CARER.
CARER started its journey in the year 2018 and in two years it has carved a niche for itself in the industry. The startup has to date treated over 400 cancer patients with 43 different cancer types. It has partnered with doctors, home care providers, diagnostic chains, genetic testing labs, pharmaceutical companies, and more than 10 leading hospital chains across the country suchas Fortis, Manipal, Aster CMI, NH, and others. This technology-driven platform has established a firm global presence and worked with patients in different parts of the world, from UK, US, Africa, South East Asia to the Middle East. Among the many projects, CARER had executed a prominent clinical pilot with HCG Hospital for patients suffering from head and neck cancer. The results of this study are being admitted for publication. Furthermore, CARER has secured seed funding in its very founding year.
“Our partnership with a reputable technology company and their connectivity with the international healthcare market has proven to be beneficial for us. This association helped us to have a better grasp of the healthcare ecosystem and following suit with the scientific methodologies that are enabled by technologies and are being developed all around the world. They have guided CARER to create a transformational integrative oncology solution, for the first time here in India. We are the first and only company that provides integrative oncology solutions to cancer patients,” she adds.
CARER has visualized its strategy towards building the largest integrative oncology technology platform that is AI and data-driven and completely focused on retrieving deeper clinical and non-clinical data points. The company will also be dedicating a section of its man oeuvres to recognizing larger clinical trials and R&D, along with brand building and patient acquisition.
“NASSCOM has been a great support system in encouraging and assisting companies such as ours that are trying to make a massive impact and solution-driven to change the way healthcare is administered. We are often connected to other large healthcare entities for various projects, through NASSCOM, which might not have been possible or as easy otherwise. The team has been extremely supportive and has taken a personal interest in helping us build valuable propositions for various projects.” Samara Mahindra, Founder & CEO of CARER.
For any further information\query you can write to us at Co-innovate@nasscom.in
AarogyaAI: Leverages contemporary technology and sciences to combat fatal infectious diseases!
Systematic integration of technology has utterly revamped the way medical care is conferred to patients, enhancing patient-physician interaction, and making healthcare more accessible & flexible than before. At the current set of circumstances where the entire world is grappling with a healthcare crisis, technology like Artificial Intelligence has helped in reducing the time spent in executing healthcare management activities at the fraction of the price.
Healthtech startup AarogyaAI is using AI-enabled software for expediting diagnosis and enabling personalized treatment within a few hours. Founded by two promising innovative women entrepreneurs Dr. Praapti Jayaswal and Avlokita Tiwari, AarogyaAI will combat lethal infectious diseases like Tuberculosis and develop an AI-driven software to diagnose Drug-resistant Tuberculosis, expediting the process of diagnosis and effective treatment.
AarogyaAI is one of the six startups that have graduated from the India Edison™ Accelerator, Cohort 2- GE Healthcare’s second startup-collaboration program that intends to nurture the startup ecosystem and work with them to create innovative and effective healthcare solutions.
The AarogyaAI software innovated by the company is deployed in the GE Edison platform. It is empowered with a Machine Learning algorithm that has the ability to make sense of complex genomic data and output an easy to comprehend drug sensitivity report which augments clinical decision-making. Thus, each patient’s antibiotic prescriptions are customized to their specific need.
“Artificial intelligence helps convert large amounts of complex data to concise factoids that can augment a doctor’s clinical decision making. The AarogyaAI’s SaaS requires minimal infrastructure and basic training to operate and can report a copper-bottomed patient’s drug susceptibility status in a few hours,” states Dr. Praapti Jayaswal, Co-Founder & CEO, AarogyaAI.
Since inception, AarogyaAI has created a buzz in the ecosystem. The firm has secured investment from one of the largest genomics companies in the world, Illumina Inc., USA. In 2019, the team at AarogyaAI was awarded the Best Pitch by Shakti – The Empathy Project. It made its way to be a part of the San Francisco-based Illumina Accelerator Program in 2020. In March 2020, AarogyaAI also won the BIRAC TiE WInER Award which is accredited to Women in Entrepreneurial Research by the Biotechnology Industry Research Assistance Council (BIRAC).
In addition, winning awards like the Indo-Sweden Healthcare Innovation Challenge, organized by the Ministry of Health and Family Welfare, Government of India, and getting on board in the GE Healthcare’s Indian EdisonTM Accelerator platform has gained it national as well as international level recognition.
“We established AarogyaAI in 2019, with the sole purpose of revolutionizing the method of treating Tuberculosis and saving lives. We have partnered with leading diagnostic labs & hospitals in India for building & validating the product. Eventually, we aim to anticipate the evolution, nature, and pattern of the bacteria, along with predicting the future drug resistance structure. We leverage AI/ML and genomics, to rapidly and comprehensively diagnose drug resistance in infectious diseases. We also intend to use AI, ML, and IoT technologies to ensure that patients even in the most remote corner of India, have access to the latest diagnostics and treatment options,” states Avlokita Tiwari, Co-Founder, AarogyaAI.
With a vision to contribute to ending tuberculosis globally, the founders are driven by the concept of translation of research into real-world application. AarogyaAI envisions assimilating years of research to combat antimicrobial resistance in infectious diseases. The company wants to employ cutting-edge technology – genomics and AI to ensure patients are provided precision diagnosis to enable effective medication. The intention is to collaborate with centers from different geographical locations in India, and abroad; and expand the database on more first and second-line anti-TB drugs. The AarogyaAI solution will be able to predict new mutations that confer drug resistance in the bacteria. AarogyaAI aims to impact human health and build facilities where no one is subjected to incorrect medication and is left to deal with very harmful side effects.
“AarogyaAI is on a vision to develop a time and cost-effective test for the drug-resistant tuberculosis. Their technology will go a long way in addressing the appropriate management of the disease burden and potentially contributing to the ending of the TB epidemic by 2030, which is one of the heath targets of the United Nations Sustainable Development Goals.” Abhijit Patil, Senior Director – AI & Analytics: Advanced Technology Group @ GE Healthcare and India EdisonTM Accelerator Cohort 2 Mentor.
JioVio Healthcare: Delivers Personalized and Predictive Maternal care using AI, IoT, and wearable technology!
Ameliorating maternal and infant health has always been a major concern for India. For years, the country has been bending over backward to reduce the maternal mortality rate by providing quality services to the expectant mother and their neonates. The outbreak of the COVID-19 pandemic has pulled the plug on the progress and has further heightened the medical hassles.
The start-up ecosystem has also been quite intrigued in driving innovation to enhance maternal health services, ensuring arrant prenatal & child care. NASSCOM CoE incubated startup, JioVio Healthcare has taken the initiative of detecting high-risk pregnancies and delivering personalized and predictive and high-quality maternal care to mothers and infants in remote places. The company is on its mission to make the journey to parenthood positive and trouble-free through the innovative healthcare technologies it has devised using AI, IoT, and wearable technology.
Harnessing technology to Save Mother and Child!
Every other woman in our country suffers from pregnancy-related complications due to poverty, lack of information, and negligence. The ardour to explore the power of technology and curate solutions and measures to support home-based or accessible antenatal & new-born care, particularly for rural and underprivileged women of the country as they appear to be deprived of the respectful and quality maternity facilities, encouraged Senthil Kumar Murugesan and Dinesh Pandian to set up JioVio Healthcare.
JioVio healthcare launched Savemom-an IoT-based maternal healthcare solutions formulated to confer end-to-end maternal care to treat life-threatening pregnancy-related intricacies, reduce maternal and infant mortality rates in remote regions. This AI-enabled IoT Kit and Telemedicine software consist of three unique devices-Allowear, Allotricorder, AlloBMI, and AlloBeat. These smart wearable and kits s are specially designed to record the significant behaviors and activities of a pregnant woman such as heart rate, sleeping order, risk factors, and other data. The additional benefit of this device is that it can be easily connected to the user’s phone via Bluetooth, the memory card in it stores the data that is directly sent to the doctor portal for further analysis. These data can be used by doctors for delivering immediate treatment and enrich the patient-doctor relationship. It’s AI integrated web application segregates patients into high and low risks categories. Using the SaveMom admin portal, both doctors and patients can view their health conditions and reports.
Harnessing technology to Save Mother and Child!
Every other woman in our country suffers from pregnancy-related complications due to poverty, lack of information, and negligence. The ardour to explore the power of technology curated solutions and measures to support home-based or accessible antenatal & new-born care, particularly into rural and underprivileged women of the country as they appear deprived of the respectful and quality maternity facilities, encouraged Senthil Kumar Murugesan and Dinesh Pandian to set up JioVio Healthcare.
JioVio healthcare launched Savemom-an IoT-based maternal healthcare solutions formulated to confer end-to-end maternal care to treat life-threatening pregnancy-related intricacies, reduce maternal and infant mortality rates in remote regions. This AI-enabled IoT Kit and Telemedicine software consist of three unique devices-Allowear, Allotricorder, AlloBMI, and AlloBeat. These smart wearable and kits are specially designed to record the significant behaviors and activities of a pregnant woman such as heart rate, sleeping order, risk factors, and other data. The additional benefit of this device is that it can be easily connected to the user’s phone via Bluetooth, the memory card in it stores the data that is directly sent to the doctor’s portal for further analysis. These data can be used by doctors for delivering immediate treatment and enrich the patient-doctor relationship. It’s AI integrated web application segregates patients into high and low risks categories. Using the SaveMom admin portal, both doctors and patients can view their health conditions and reports.
“NASSCOM CoE played an important role in giving us the traction we needed to create a niche in the ecosystem. The constant mentorship and support of CoE have got a lot of exposure and recognition to our innovation. They have helped us in setting up a team in Bangalore and securing several grants and awards such as Elevate 100 award,” states Senthil Kumar Murugesan, CEO Co-Founder- JioVio Healthcare.
The team of JioVio Healthcare is leaving no stone unturned in executing medical facilities and helping hospitals in battling the medical crisis spawned by the COVID-19 pandemic. They have availed IT and healthcare prowess and deep tech IoT-based solutions to devise QCARE (Quarantine monitoring system using IoT medical device), an independent android App that also serves as an integrated APK solution and supports the screening and corona awareness. It advances cost-effective preventive PPE kits, Portable UV Sterilizer/Sanitizer, Hybrid Mask, and products, assures the safety of the people in varied living and working contexts.
“Since a woman can only understand the problems of another woman, we decided to bring proficient and enthusiastic women together to form a team that will ardently work towards delivering innovation to save lives,” he adds.
Based in Madurai, Jio Vio Healthcare has to date delivered 22,856 home-based antenatal care, identified 382 high-risk mothers, 1428 mothers have delivered their babies successfully, and onboard more than 300 mothers every month. This ideal prenatal solution is accredited by Maharashtra and Kerala Government, more than 52 villages have adopted and implemented this avant-garde liberatory App. Among the many achievements, the startup has won the NASSCOM Technagage Award for “SaveMom” IoT-based wearable innovation for pregnant mothers in tribal villages and bagged the ‘Gifted Citizen 2019’ Award in CDI Event organized by the Nobel Prize team in Mexico. The creators of JioVio Healthcare are constantly endeavouring to take the ingenious initiative to a new level, focusing on drafting a beneficial healthcare plan for women and their families both in the rural and urban provinces.
Absstem Technologies: Helping Hospitals produce their own Medical oxygen 24/7!
The second wave of coronavirus has hit the country hard. With India witnessing a massive spike in COVID-19 patients admitted in the hospitals needing medical oxygen for survival, we endure a severe health crisis as there is a shortage of medical oxygen and an inadequate supply chain. Big or small, hospitals are undergoing a tough time in arranging an adequate amount of oxygen supply to meet this special requirement in patient care. The government, private entities, and people are bending over backward to overcome this catastrophic situation. DRDO’s decision of earmarking On-Board Oxygen Generation System (OBOGS) used in Tejas Light Combat Aircraft (LCA) for civilian use and coronavirus duty is an innovative case in point today.
As we are acquiring oxygen cylinders from factories in India and across the globe, the chances of repeated handling are respectively high. Considering the current scenario this process may inflate the risk of contaminating the cylinders which can make the situation even more complex. The sanitization protocols issued by the government and several other conditions are further disrupting the on-time delivery of oxygen cylinders, giving rise to impediments such as unavailability of oxygen, increase in the price, and so forth.
Absstem Technologies’ PSA-based disruptive solution-Medical Oxygen Generator-MedO surfaces as the savior which is capable of measuring up the sudden surge in the demand for oxygen in the country. This onsite Medical oxygen solution’s unique and high-tech features can generate medical oxygen instantly at the hospital site. It is affordable, convenient, reliable, safe generates oxygen 24/7, and requires minimum maintenance.
This Delhi-based startup, led by Mohit Sharma has to date executed over 18 deployments in different hospitals in India and across the world. Today, the team is putting their brains together to help hospitals be self-reliant by having an uninterrupted and continuous supply of oxygen.
How does it function?
The oxygen concentrator consists of an air compressor that pulls atmospheric air into the system, Refrigeration Dryer that removes water vapor from compressed air, a Multistage filtration system that removes impurities, and a PSA system to remove nitrogen and other trace gases and process oxygen and HEPA filters to remove bacterial contamination.
The medical oxygen generator leverages the next-gen PSA technology and avails the atmospheric air as raw material to convert oxygen into medical-grade oxygen. It comes with two adsorbers that are filled with zeolite molecular sieves which detect and absorb nitrogen from the air and allow oxygen to flow into the storage tank as the end product. To conserve purity and comply with the guidelines set by US Pharmacopeia, Indian Pharmacopeia, and UK Pharmacopeia, Absstem had installed an oxygen analyzer within the system that keeps a check on the quality of the oxygen. This continuous flow process is monitored by a specially devised microcontroller. In the entire operation, the air is permitted to pass through one of the adsorbers whilst the adsorber edges near the saturation point. Whereas, the other adsorber is employed to regenerate and maintain the continuous supply of medical oxygen.
Furnished with a user-friendly touch-screen interface, the MedO-eye displays operation parameters, and real-time oxygen purity. For data controlling and logging facilities, the equipment allows the tracing, displaying, and storing of oxygen purity data, running hours of air compressor, and filters which can further be availed for audits and certifications purposes. The buzzer installed in it beeps when the systems require maintenance. Its multistage filtration protects the molecular sieves from oil and dust particles while the additional filters drain moisture using an ADV (Automatic Drain Value).
The ergonomic design, robust steel structure, and advanced HMI not only makes it a competent oxygen producer but also show longevity in a dust-moisture-free environment. The oxygen concentrator skid system connects directly to the MGPS / Pipeline with the existing oxygen cylinder station acting as an emergency backup. The oxygen concentrator has various models with the oxygen flow capacity ranging from 100 LPM to 1400 LPM.
The installation cost of these oxygen concentrators is recovered within 12-15 months. The molecular sieves used in the system have a life of over 10 years and the maintenance cost is really low. The overall cost of medical oxygen comes down by around 70% as compared to oxygen cylinders.
Absstem technologies aim to remain ahead of the curve by supporting hospitals with products like MedO, Medical Oxygen High-Pressure Systems, and MOGPS- Medical Gas Pipeline System. It is high time to embrace these life-saving solutions to beat the struggle with the shortage of oxygen supply in hospitals and stay united to save lives.
SenseGiz-A vision to make the world appreciably productive, safer and secure place to live in!
Advanced technologies like IoT, AI, and Big Data have played an extremely pivotal role in keeping the world digitally competent and connected. The perseverance of staying ahead of the curve kindled organizations to truly leverage the power of these ground-breaking solutions to refine the ways of conducting businesses, establishing better customer understanding, apprehend lucrative growth, and furtherance. At this age, these contemporary technologies are patently metamorphosing every industry including healthcare, manufacturing, automotive, last mile, and many more.
To help organizations and businesses understand the significance of the technology solutions and settle on the most felicitous one, to boost their efficiency and productivity, tech-enthusiast Abhishek Latthe brought into being SenseGiz- a tech-driven enterprise that focuses on building cost-effective and streamlined enterprise and industrial IoT products for sensor-based Condition Monitoring, Predictive Maintenance, Perimeter Security and real-time asset/people tracking applications, curating and combining the proprietary mesh connected hardware, cloud, analytics, and apps.
“We envisage making the world appreciably more productive, safer and secure place to live in, with access to affordable and coherent technology that is contrived and fashioned by our agile and inventive teams. Through SenseGiz we are putting forward a gamut of versatile IoT cloud and analytics solutions to add value to the lives of our customers, assisting them to improve their productivity, safety, and security. We have designed industry-based Cloud supports APIs for users who wish to build their applications on top of our back end and leave all the computations and data storage tasks to our intelligent cloud. Our far-reaching solutions range from Asset & People tracking, Cold Chain Monitoring, Perimeter Security, In-Plant Fleet Management, Predictive Maintenance,” informs Abhishek Latthe,
A NASSCOM CoE Iot & AI incubated start-up, SenseGiz’s flagship offering COIN collects condition & indoor location data which is then stored in the cloud for users to avail it when needed. This device is designed with multiple sensors and monitors temperature, humidity, motion vibration, assets, and even people in real-time. It helps users to take data-driven decision, monitor key metrics, generate reports and accurately analyse data to get actionable insights of the operations. “Through our COIN, we have created a proprietary low-powered point-to-point mesh network of tiny low-cost sensor nodes. The mesh network is based on top of Bluetooth 5, the mesh has an effective communication speed of 1 Mbps suitable for high speed and high data applications with Self-learning and self-healing capabilities. Each COIN has an effective range of 150 ft per node. The product is ready for mass-scale customer sales, thus taking the first movers’ advantage. The COIN, Gateway, and SENSEGIZ SAAS have supported many companies to maintain Social Distancing and Historical Contact Tracing too,” he states.
Conscious of the challenges organizations and hospitals are facing in maintaining social distancing and contract tracing, SenseGiz stepped forward to help them get the better of the pandemic crisis through solutions like Option A- Enterprise and Option B- PRO. “Option A (Enterprise) is suitable if customers want geo-fencing and location-based data of who is where and over-crowding alerts, and Option B (Pro) is suitable if the customer needs enforcement of social distancing and contact tracing, both the products are MADE IN INDIA,” he adds.
In the seven years of its existence, SenseGiz has come a long way. These out-of-the-box innovations have bagged outstanding recognitions including NASSCOM -Iconic Startup, NASSCOM – National level delegation to Japan, Govt of India- IoTCenter of Excellence, SAMADHAN Award by MHRD, and BCIC Emerging Star Award- 2021, and several others. “It was an astonishing journey, we have moved forward successively. At present, we have a team of 52 who bring with them dexterity of varied domains. Apart from India, we have extended our presence to the US, Japan, Spain, and South Africa as well. Our products are sold worldwide and are also deploying solutions to 40+ large customers in India and abroad, witnessing a cumulative revenue of INR 5.5 crores. SenseGiz’s Sentinel solution for social distancing and contact tracing is deployed for the bio bubble maintenance for the India-England cricket series. The bands were being used by the players and other staffs within the big bubble,” he states.
Emphasizing its experience of being a NASSCOM CoEincubated startup, Abhishek avers, “It is a massive opportunity to be associated with CoE and benefit from various connections, networks, events that it brings to a startup like ours. The experience has only been overwhelming, to say the least. We could reach out and establish business relations with a lot of corporates. The exhibitions, conclaves, business events, and varied initiatives have added a lot of value to our company’s portfolio. We thank NASSCOM CoE for the constant handholding and extended support since incubation.”
The firm has planned a bright future, aiming to devise IoT products considering the different industrial needs including energy, mobility (connected cars), and many others. “We are very determined about developing new products like High range COIN, 5G, Analytics, and will constantly looking for strategic partnership opportunities,” he concludes.
Tackling The Cancer Epidemic Using AI
In recent times, breast cancer has become the most common type of cancer affecting women worldwide accounting for 25% of all cancer cases and affected 3.5 million people in 2017-18. Early diagnosis in these cases significantly increases the chances of survival. The key challenge in cancer detection is how to classify tumours into malignant or benign. Research indicates that most experienced physicians can diagnose cancer with 79% accuracy while using artificial intelligence based diagnosis, it is possible to achieve 91% accuracy.
NASSCOM CoE-IoT & AI & Eqounix Tech Lab organised a hands-on session on 28th September 2019, 10am onwards at the CoE Gurugram center on Breast Cancer detection. This was a paid session and there were over 50 attendees, consisting of basic & advanced developers from enterprises like Sopra Steria, United Health Group, TCS, HCL, Inventum Technologies, Publicis Sapient, Globallogic etc and startups like Attentive AI, Empass, Anasakta Labs, NEbulARC, SirionLabs & Vision Networkz. Students from ICGEB/JMI, Indira Gandhi Delhi Technical University etc also participated in the session.
The session first half focussed on Wisconsin Diagnostic Cancer (WDBC) & Invasive Ductal Carcinoma (IDC) datasets insights, Visualization of Dataset, feature selection and why they are chosen and how the physical parameters are translated into a dataset. In the second part, the focus was on Feature Selection and CNN, random forest based classification of cancer as malignant or benign followed by the optimised the deployment strategy & cost estimation
WISCONSIN DIAGNOSTIC BREAST CANCER (WDBC):
The samples consist of visually assessed nuclear features of Fine Needle Aspirates (FNAs) taken from patients. Attributes 3 to 11 were used to form a 9-dimensional vector which was used to obtain a neural network to discriminate between benign and malignant samples. Cross-validation was used to project the accuracy of the diagnostic algorithm.
| Field | Attribute |
| 1 | Sample code number |
| 2 | Class: 2 for benign, 4 for malignant |
| 3 | Clump Thickness |
| 4 | Uniformity of Cell Size |
| 5 | Uniformity of Cell Shape |
| 6 | Marginal Adhesion |
| 7 | Single Epithelial Cell Size |
| 8 | Bare Nuclei |
| 9 | Bland Chromatin |
| 10 | Normal Nucleoli |
| 11 | Mitoses |
INVASIVE DUCTAL CARCINOMA (IDC)
Invasive Ductal Carcinoma dataset originally consisted of 162 slide images, scanned at 40x. From that, 277,524 patches of 50×50 pixels (which is converted to 32 x 32pixels to fit the model architecture) were extracted, including, 198,738 IDC negative examples & 78,786 IDC positive examples. Each image in the dataset is labelled based on the following parameters:
- Patient ID: 10253_idx5
- x-coordinate of the crop: 1,351
- y-coordinate of the crop: 1,101
- Class label: 0 (0 indicates no IDC while 1 indicates IDC)
CNN Architecture used:
- Used exclusively 3×3 CONV filters, similar to VGGNet
- Stacked multiple 3×3 CONV filters on top of each other prior to performing max-pooling (again,
similar to VGGNet)
- But unlike VGGNet, used depthwise separable convolution rather than standard convolution layers
- Keras Sequential API is used to build CancerNet
The model achieved 86% classification accuracy, 85% sensitivity, and 85% specificity.
CODE REPOSITORY:
https://bitbucket.org/tdequonix/cancer_detect_meetup_resources/src/master/
Enter git clone and the repository URL at your command line:
git clone https://shantanugaur@bitbucket.org/tdequonix/cancer_detect_meetup_resources.git
- build_dataset.py : Builds the dataset by splitting images into training, validation and testing sets.
- cancernet.py : Contains CancerNet breast cancer classification CNN
- train_model.py : Responsible for training and evaluation of Keras classification model
DATASET & PRESENTATION:
https://drive.google.com/open?id=1kgbtXSkDhDXK1aTCb8l1GvQcOn3iTjZQ
NEXT SESSION:
The next session will be focussed on the Prognostic system. This recently put into clinical practice, is a method that predicts when the cancer is likely to recur in patients that have had their cancers excised. This gives the physician and the patient better information with which to plan treatment and may eliminate the need for a prognostic surgical procedure. The novel feature of the predictive approach is the ability to handle cases for which cancer has not recurred as well as cases for which cancer has recurred at a specific time.
CDAC Workshop on Healthcare Data Standards, Data Privacy and Data Security
Electronic/Personal Health Records (EHR/PHR) and Hospital Information Management Systems (HIMS) are at the core of healthcare data aggregation, as innovators strive to integrate their technology solutions with the country’s existing EHR/PHR and HIMS databases.
C-DAC, an entity of MeitY, is at the helm of innovation in technology for several industries including healthcare. For the last 20+ years C-DAC has been working on Health Information Solutions covering multiple business needs prioritised by the Government.
NASSCOM CoE-IoT organized a workshop where the leadership teams from C-DAC provided an overview of the entire health-stack developed and implemented by them. Nearly 30 Startups participated in the workshop to learn about the relevance of EHR2016 standards, provisions in the draft DISHA guidelines on Data Privacy & Security and the modalities for integrating their digital solutions with C-DAC applications through API integration.
An interactive Panel Discussion was moderated by Raghuram Janapareddy, Director (Lifesciences & Healthcare), NASSCOM CoE with the panellist Mr.Vivek Khaneja Executive Director, Mr.Pavin Srivastava, Associate Director and Mr.Rajiv Yadav Associate Director. The startups clarified their doubts on Data Security/Privacy, EHR Standards and the opportunities to work with C-DAC. Later Startups made presentations about their solutions for the benefit of the C-DAC Team.
